Gelonghui November 7th | Haitong Securities research reports pointed out that haitong sec (600079.SH) controlling shareholder restructuring investors have made progress, the company's revenue is stable and growing. In the third quarter, the revenue was 6.282 billion yuan (+9.66% year-on-year), with a net income attributable to the parent company of 0.479 billion yuan (+7.57% year-on-year). As of October 22, 2024, a total of 6 restructuring investors have passed the formal review and completed the payment of application guarantee deposits, becoming qualified applicants for restructuring investors and obtaining the qualification to participate in investor elections. Referring to comparable company valuations, considering the stability of the anesthetic industry in which the company operates and its leading position, the company is given a 2024 PE ratio of 15-19 times, corresponding to a reasonable value range of 20.02-25.36 yuan, and an "outperform the market" rating.